OptoMap MonnacoPro

Optomap non-invasively captures an instantaneous, ultra-widefield digital image of the retina, revealing important information for the comprehensive evaluation of systemic and ocular health. The image, which is captured in less than half a second, enhances clinical care, patient satisfaction, and practice efficiency. It is performed quickly and easily which enables practitioners to spend more time diagnosing and educating rather than gathering information. An optomapis performed as part of a comprehensive eye exam. An optomap image provides the practitioner with a tool to help discover retinal disease, and assist in the diagnosis of eye conditions – and potentially other health conditions – early. It also enables the practitioner to effectively determine the next course of action.

Early detection of any retinal abnormality may lead to earlier and safer treatments and in many cases prevent vision loss. An optomap should be performed annually regardless of symptoms, thereby allowing doctors to observe subtle changes occurring as their patient’s age.

Since its inception, millions of optomap images have been taken worldwide, aiding in the detection and diagnosis of serious eye conditions such as diabetic retinopathy, retinal detachments, macular degeneration, and other pathologies like melanomas.

About Optos:

Optos has the vision to be The Retina Company. We aim to be recognized as a leading provider of devices and solutions to eyecare professionals for improved patient care. Optos' core devices produce ultra-widefield, high-resolution digital images (optomap) of approximately 82% of the retina, something no other device is capable of doing in a single image.